Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.59 |
| ▸ | NCF1 | P14598 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LSS | P48449 | 1/20 | 0.46 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.46 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.44 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6227149 | 1.00 | HRH3 (0.59) | HRH3NCF1MEN1KMT2ALSS | |
| SCHEMBL6226795 | 0.98 | HRH3 (0.61) | HRH3NCF1MEN1KMT2ALSS | |
| SCHEMBL6226793 | 0.98 | HRH3 (0.61) | HRH3NCF1MEN1KMT2ALSS | |
| SCHEMBL8084041 | 0.87 | HRH3 (0.53) | HRH3MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL13577677 | 0.85 | HRH3 (0.69) | HRH3MEN1KMT2ALSSHRH4 | |
| SCHEMBL30596544 | 0.80 | HRH3 (0.67) | HRH3MEN1KMT2AHRH4ALDH1A1 | |
| SCHEMBL3440556 | 0.80 | HRH3 (0.67) | HRH3MEN1KMT2AHRH4ALDH1A1 | |
| SCHEMBL7319627 | 0.80 | HRH3 (0.67) | HRH3MEN1KMT2AHRH4ALDH1A1 | |
| SCHEMBL23269704 | 0.80 | LSS (0.57) | HRH3NCF1MEN1KMT2ALSS | |
| SCHEMBL8532857 | 0.80 | HRH3 (0.56) | HRH3MEN1KMT2ALSSHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045832-B1 | NOVEL URETHANES, THIO AND DITHIO ANALOGUES, THE SALTS THEREOF, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE AND METHOD FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-03-23 | — | — | EP | disclosed |
| US-20020019536-A1 | Poultry feed for low cholesterol eggs | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6346545-B1 | POULTRY FEED FOR LOW CHOLESTEROL EGGS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-02-12 | — | — | US | disclosed |
| EP-1045832-A2 | NOVEL URETHANES, THIO AND DITHIO ANALOGUES, THE SALTS THEREOF, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE AND METHOD FOR THE PRODUCTION THEREOF | Boehringer Ingelheim Pharma KG (DE) | 2000-10-25 | — | — | EP | disclosed |
| WO-1999029662-A2 | URETHANES, THIO AND DITHIO ANALOGUES, THE SALTS THEREOF, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE AND METHOD FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019536-A1 | Poultry feed for low cholesterol eggs | CYP7A1, NR5A1, AUP1 | HRH3 3352/4885NCF1 1412/4885MEN1 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.